Expression of VEGF receptors in cocultured neuroblastoma cells

被引:22
作者
Beierle, EA [1 ]
Dai, W [1 ]
Langham, MR [1 ]
Copeland, EM [1 ]
Chen, MK [1 ]
机构
[1] Univ Florida, Dept Surg, Gainesville, FL 32610 USA
关键词
neuroblastoma; VEGF; flt-1; KDR; flt-4; neuropilin-1; neuropilin-2; coculture; IMR-32; SK-N-DZ;
D O I
10.1016/j.jss.2004.01.002
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. VEGF is best known for its angiogenic properties. We have found that VEGF expression is increased in neuroblastoma cells cocultured with hepatocytes. In addition, we have previously shown that neuroblastoma cells cultured with exogenous VEGF have an increase in the expression of VEGF receptors. Therefore, we hypothesized that the expression of VEGF receptors would be up-regulated in neuroblastoma cells grown in the coculture environment. Materials and methods. Two neuroblastoma cell lines (IMR-32 or SK-N-DZ) are used. These cells are cultured alone and in a coculture system with hepatocytes. Message for VEGF and the VEGF receptors KDR, flt-1, flt-4, neuropilin 1 (NRP-1), and neuropilin 2 (NRP-2) are measured with RT-PCR. Flt-4, NRP-1, and NRP-2 protein expression is measured with Western blot. Results. The receptors KDR and flt-1 are not detected in either cell line in either control or coculture conditions. Message for VEGF and flt-4 is significantly increased in the cocultured IMR-32 cells, while that for NRP-1 and NRP-2 is unchanged in these cells. VEGF and its receptors are unchanged in cocultured SK-N-DZ cells. Conclusions. Neuroblastoma cells express specific VEGF receptors that are differentially regulated in the different cell lines. These findings suggest that the heterogeneity of neuroblastomas may limit the utility of targeting VEGF and its receptors as sole treatments for the tumor, and that successful therapies will be dependent upon the specific biology of the tumor. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:56 / 65
页数:10
相关论文
共 62 条
[1]  
André T, 2000, INT J CANCER, V86, P174, DOI 10.1002/(SICI)1097-0215(20000415)86:2<174::AID-IJC5>3.3.CO
[2]  
2-5
[3]  
Barleon B, 1997, CANCER RES, V57, P5421
[4]   Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[5]   Differential expression of Bcl-2 and Bax may enhance neuroblastoma survival [J].
Beierle, EA ;
Dai, W ;
Iyengar, R ;
Langham, MR ;
Copeland, EM ;
Chen, MK .
JOURNAL OF PEDIATRIC SURGERY, 2003, 38 (03) :486-491
[6]   VEGF upregulates BCL-2 expression and is associated with decreased apoptosis in neuroblastoma cells [J].
Beierle, EA ;
Strande, LF ;
Chen, MK .
JOURNAL OF PEDIATRIC SURGERY, 2002, 37 (03) :467-471
[7]   VEGF is upregulated in a neuroblastoma and hepatocyte coculture model [J].
Beierle, EA ;
Strande, LF ;
Berger, AC ;
Chen, MK .
JOURNAL OF SURGICAL RESEARCH, 2001, 97 (01) :34-40
[8]   Neuroblastoma and hepatocyte coculture conditioned media alter apoptosis [J].
Beierle, EA ;
Strande, LF ;
Geldziler, BD ;
Chen, MK .
JOURNAL OF SURGICAL RESEARCH, 2000, 90 (02) :113-118
[9]  
Borgstrom P, 1996, CANCER RES, V56, P4032
[10]   EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) AND ITS RECEPTORS IN BREAST-CANCER [J].
BROWN, LF ;
BERSE, B ;
JACKMAN, RW ;
TOGNAZZI, K ;
GUIDI, AJ ;
DVORAK, HF ;
SENGER, DR ;
CONNOLLY, JL ;
SCHNITT, SJ .
HUMAN PATHOLOGY, 1995, 26 (01) :86-91